|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A multi-centre randomised, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of ART621 following multiple dose administration for 3 months in patients with rheumatoid arthritis concomitantly taking methotrexate
|
|
|
Disease Condition |
Rheumatoid Arthritis
|
|
|
Phase of Trial |
Phase-2
|
Discipline |
Orthopaedics
|
|
|
Start date of Trial |
4/6/2009
|
Closing Date of Trial |
11/6/2010
|
|
|
|